FdaApplication
BLA 761192
Identifiers
- fda_app_no: BLA761192
Properties
| Property | Value |
|---|---|
| applicant_name | Vericel Corporation |
| application_type | BLA |
| approval_date | 2022-12-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEXOBRID | ANACAULASE-BCDB | 8.8% (1.94GM) | For Topical Gel |
| NEXOBRID | — | 8.8% (4.85GM) | For Topical Gel |
2 products